Potential pathogenic role of β-amyloid1–42–aluminum complex in Alzheimer's disease ☆

[1]  Jianxiu Wang,et al.  Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance† , 2007 .

[2]  C. Behl,et al.  Cholesterol-Like Effects of Selective Cyclooxygenase Inhibitors and Fibrates on Cellular Membranes and Amyloid-β Production , 2007, Molecular Pharmacology.

[3]  R. Glockshuber,et al.  Amyloid-β Aggregation , 2007, Neurodegenerative Diseases.

[4]  L. Bartolotti,et al.  Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein. , 2007, Biochemistry.

[5]  Maolian Chen,et al.  Oxidation artifacts in the electrospray mass spectrometry of Abeta Peptide. , 2007, Analytical chemistry.

[6]  W. Banks,et al.  Aluminum complexing enhances amyloid β protein penetration of blood–brain barrier , 2006, Brain Research.

[7]  Yun-Ru Chen,et al.  Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42 , 2006, Journal of Biological Chemistry.

[8]  B. Lai,et al.  Metal exposure and Alzheimer's pathogenesis. , 2006, Journal of structural biology.

[9]  J. Busciglio,et al.  Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.

[10]  G. Forloni,et al.  Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions. , 2006, Biochemistry.

[11]  J. Walton,et al.  Aluminum in hippocampal neurons from humans with Alzheimer's disease. , 2006, Neurotoxicology.

[12]  D. Selkoe,et al.  Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.

[13]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[14]  C. Masters,et al.  Amyloid-β Peptide Disruption of Lipid Membranes and the Effect of Metal Ions , 2006 .

[15]  W. Klein,et al.  Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease , 2006, Journal of Biological Chemistry.

[16]  F. Stellato,et al.  Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes , 2006, European Biophysics Journal.

[17]  Tatsuo Yamada,et al.  Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides , 2005, Experimental Neurology.

[18]  F. Ricchelli,et al.  Aluminum-triggered structural modifications and aggregation of β-amyloids , 2005, Cellular and Molecular Life Sciences CMLS.

[19]  Z. Guan,et al.  Oxidative stress induced by beta-amyloid peptide1–42 is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells , 2005, Neurochemistry International.

[20]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[21]  C. Barrow,et al.  Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide. , 2005, Biophysical journal.

[22]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[23]  B. Penke,et al.  Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells , 2003, Brain Research Bulletin.

[24]  Roberto Lucchini,et al.  The role of metals in neurodegenerative processes: aluminum, manganese, and zinc , 2003, Brain Research Bulletin.

[25]  P. Zatta.  Metal Ions and Neurodegenerative Disorders , 2003 .

[26]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[27]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[28]  G. Krafft,et al.  In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.

[29]  George Perry,et al.  Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.

[30]  C. Masters,et al.  Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-β Peptide with Membrane Lipid* , 2003, The Journal of Biological Chemistry.

[31]  L. K. Baker,et al.  Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability* , 2002, The Journal of Biological Chemistry.

[32]  Rustam Azimov,et al.  The channel hypothesis of Alzheimer’s disease: current status , 2002, Peptides.

[33]  W. Müller,et al.  Membrane-disordering effects of β-amyloid peptides , 2001 .

[34]  David R. Brown.  Copper and prion disease , 2001, Brain Research Bulletin.

[35]  Masahiro Kawahara,et al.  Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of β-amyloid protein , 2001, Brain Research Bulletin.

[36]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[37]  C. Enzinger,et al.  Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes. , 2000, Molecular membrane biology.

[38]  And J. Sklansky,et al.  Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. , 2000, Biochemistry.

[39]  H. Takeuchi,et al.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. , 2000, Biochemistry.

[40]  C. Masters,et al.  Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.

[41]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[42]  W. Forbes,et al.  Is exposure to aluminum a risk factor for the development of Alzheimer disease?--Yes. , 1998, Archives of neurology.

[43]  D. Beauchemin,et al.  A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. , 1998, Analytical chemistry.

[44]  L. Duffy,et al.  Interaction of synthetic Alzheimerβ-protein-derived analogs with aqueous aluminum: A low-field27Al NMR investigation , 1995, Journal of protein chemistry.

[45]  M. Shearman,et al.  The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid Peptides , 1995 .

[46]  K. Muramoto,et al.  Aluminum Promotes the Aggregation of Alzheimer′s Amyloid β-Protein in Vitro , 1994 .

[47]  B. Lentz,et al.  Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. , 1993, Chemistry and physics of lipids.

[48]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[49]  W. D. Ehmann,et al.  Laser microprobe analysis of brain aluminum in Alzheimer' disease , 1993, Annals of neurology.

[50]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[51]  E. Perry,et al.  ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE , 1986, The Lancet.

[52]  C. Bronner,et al.  Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene. , 1985, Biochimica et biophysica acta.

[53]  M. Folin,et al.  Comparative effects of Abeta(1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures. , 2007, Journal of Alzheimer's disease : JAD.

[54]  M. Valtorta,et al.  Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis. , 2007, The international journal of biochemistry & cell biology.

[55]  A. Miu,et al.  Aluminum and Alzheimer's disease: a new look. , 2006, Journal of Alzheimer's disease : JAD.

[56]  P. Zatta.  Aluminum and Alzheimer's disease: a Vexata Questio between uncertain data and a lot of imagination. , 2006, Journal of Alzheimer's disease : JAD.

[57]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[58]  D. Butterfield,et al.  Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity. , 2004, Journal of Alzheimer's disease : JAD.

[59]  Christopher Exley,et al.  Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[60]  S. Shankar,et al.  Aluminium in Alzheimer’s disease: are we still at a crossroad? , 2004, Cellular and Molecular Life Sciences CMLS.

[61]  M. Kirkitadze,et al.  Amyloid (cid:1) -protein (A (cid:1) ) assembly: A (cid:1) 40 and A (cid:1) 42 oligomerize through distinct pathways , 2002 .

[62]  G. Bitan,et al.  Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS* , 2001 .

[63]  P. Zatta.  Controversial aspects of aluminum(III) accumulation and subcompartmentation in Alzheimer's disease , 1993 .

[64]  B. V. D. Meer.  Biomembrane structure and dynamics viewed by fluorescence. , 1988 .